ConductScience.org, home

Paper41997362

Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling.

Park K and 8 others. Cell Mol Gastroenterol Hepatol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling. Papers, record 41997362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41997362

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling.
PubMed
Journal
Cell Mol Gastroenterol Hepatol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-09-14
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Park KKihyoun
2Kim JYJoon Yong
3Roh SWSeong Woon
4Savaliya BPBansi P
5Turner CACarys A
6Pirius NENicholas E
7LaRusso NFNicholas F
8Song KKyoungsub
9O'Hara SPSteven P

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholangitis, SclerosingMajor topic
Transforming Growth Factor beta1Major topic
Smad ProteinsMajor topic
InflammationMajor topic
Animals
Signal Transduction
Mice
Disease Models, Animal
Humans
Male
Mice, Inbred C57BL
Mice, Knockout
Liver
Liver Cirrhosis

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132243703Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.Liver Int2020https://conductscience.org/library/papers/32243703PubMed
212971963Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats.J Hepatol2003https://conductscience.org/library/papers/12971963PubMed
312091489LXR/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells.J Lipid Res2002https://conductscience.org/library/papers/12091489PubMed
428030369Intestinal microbiota in primary sclerosing cholangitis.Curr Opin Gastroenterol2017https://conductscience.org/library/papers/28030369PubMed
530730351Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial.Am J Gastroenterol2019https://conductscience.org/library/papers/30730351PubMed
628376583Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Gut Liver2018https://conductscience.org/library/papers/28376583PubMed
731897266Challenges of Cholangiocarcinoma Detection in Patients with Primary Sclerosing Cholangitis.J Anal Oncol2012https://conductscience.org/library/papers/31897266PubMed
822993202Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.Gut2013https://conductscience.org/library/papers/22993202PubMed
919243003A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.Liver Transpl2009https://conductscience.org/library/papers/19243003PubMed
1034247022Genomic analysis of Leuconostoc citreum TR116 with metabolic reconstruction and the effects of fructose on gene expression for mannitol production.Int J Food Microbiol2021https://conductscience.org/library/papers/34247022PubMed
1137923895A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cells.Sci Rep2023https://conductscience.org/library/papers/37923895PubMed
1235594710Plumbagin ameliorates bile duct ligation-induced cholestatic liver injury in rats.Biomed Pharmacother2022https://conductscience.org/library/papers/35594710PubMed
1324510619Dextran sulfate sodium (DSS)-induced colitis in mice.Curr Protoc Immunol2014https://conductscience.org/library/papers/24510619PubMed
1436189347The gut microbiota-bile acid axis: A potential therapeutic target for liver fibrosis.Front Cell Infect Microbiol2022https://conductscience.org/library/papers/36189347PubMed
1521844910The intestinal microbiota and chronic disorders of the gut.Nat Rev Gastroenterol Hepatol2011https://conductscience.org/library/papers/21844910PubMed
1634256014Gut-microbiota-targeted diets modulate human immune status.Cell2021https://conductscience.org/library/papers/34256014PubMed
1733676893The phosphorylation of the Smad2/3 linker region by nemo-like kinase regulates TGF-β signaling.J Biol Chem2021https://conductscience.org/library/papers/33676893PubMed
1826550019Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway.Evid Based Complement Alternat Med2015https://conductscience.org/library/papers/26550019PubMed
1930052539Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.Eur J Gastroenterol Hepatol2018https://conductscience.org/library/papers/30052539PubMed
2032633158Open-label prospective therapeutic clinical trials: oral vancomycin in children and adults with primary sclerosing cholangitis.Scand J Gastroenterol2020https://conductscience.org/library/papers/32633158PubMed

See all 53 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42097543From Kimchi to Primary Sclerosing Cholangitis: Leuconostoc citreum LB-P8 as a Microbiome-Based Therapeutic Approach.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/42097543

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41997362

GET https://conductscience.org/api/papers/v1/41997362/references?page=2